Negative cross talk between NFAT1 and Stat5 signaling in breast cancer

Molecular Endocrinology

Volumn 25, Issue 12, 2011, Pages 2054-2064

  Zheng, Jiamao ^a   Fang, Feng ^a   Zeng, Xianke ^a   Medler, Terry R ^a   Fiorillo, Alyson A ^a   Clevenger, Charles V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; SMALL INTERFERING RNA; STAT5 PROTEIN; STAT5A PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA BINDING; GENE EXPRESSION; GENE INTERACTION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES, RENILLA; LYMPH NODES; LYMPHATIC METASTASIS; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TISSUE ARRAY ANALYSIS; TRANSCRIPTIONAL ACTIVATION;

EID: 82055184017     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1141     Document Type: Article

References (37)

1. Darnell Jr JE 1997 STATs and gene regulation. Science 277:1630-1635
2. Horvath CM 2000 STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25:496-502
3. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11:179-186
4. Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, Hissong BD, Li D, Durum SK, Jiang Q, Bhandoola A, Hennighausen L, O'Shea JJ 2006 Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci USA 103:1000-1005
5. Bromberg J 2002 Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142
6. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H 2004 Signal transducer and activator of transcription- 5 activation and breast cancer prognosis. J Clin Oncol 22:2053-2060
7. Tan SH, Nevalainen MT 2008 Signal transducer and activator of transcription 5A/B in prostate and breast cancers. Endocr Relat Cancer 15:367-390
8. Brockman JL, Schuler LA 2005 Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter. Mol Cell Endocrinol 239:45-53
9. Ren S, Cai HR, Li M, Furth PA 2002 Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 21:4335-4339
10. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H 2005 Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24:746-760
11. Fang F, Rycyzyn MA, Clevenger CV 2009 Role of c-Myb during PRL-induced Stat5a signaling in breast cancer cells. Endocrinology 150:1597-1606
12. Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP 2008 Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol 28:7168-7181
13. Yiu GK, Toker A 2006 NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 281: 12210-12217
14. Clevenger CV, Plank TL 1997 Prolactin as an autocrine/paracrine factor in breast tissue. J Mammary Gland Biol Neoplasia 2:59-68
15. Aramburu J, Yaffe MB, Ló pez-Rodriguez C, Cantley LC, Hogan PG, Rao A 1999 Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285:2129-2133
16. Ihle JN 1996 STATs: signal transducers and activators of transcription. Cell 84:331-334
17. Magne ́ S, Caron S, Charon M, Rouyez MC, Dusanter-Fourt I 2003 STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. Mol Cell Biol 23:8934-8945
18. Peng B, Sutherland KD, Sum EY, Olayioye M, Wittlin S, Tang TK, Lindeman GJ, Visvader JE 2002 CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity. Mol Endocrinol 16:2019-2033
19. Zhu M, John S, Berg M, Leonard WJ 1999 Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNγ-mediated signaling. Cell 96:121-130
20. Nakajima H, Brindle PK, Handa M, Ihle JN 2001 Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription. EMBO J 20:6836-6844
21. Ogawa S, Satake M, Ikuta K 2008 Physical and functional interactions between STAT5 and Runx transcription factors. J Biochem 143:695-709
22. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell Jr JE 1996. Two contact regions between Stat1 and CBP/ p300 in interferon γ signaling. Proc Natl Acad Sci USA 93:15092-15096
23. Sengupta S, Vonesch JL, Waltzinger C, Zheng H, Wasylyk B 2000 Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J 19:6051-6064
24. Cocolakis E, Dai M, Drevet L, Ho J, Haines E, Ali S, Lebrun JJ 2008 Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. J Biol Chem 283: 1293-1307
25. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, Wakefield LM 2003 TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 112:1116-1124
26. Im SH, Rao A 2004 Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. Mol Cells 18:1-9
27. Ranger AM, Gerstenfeld LC, Wang J, Kon T, Bae H, Gravallese EM, Glimcher MJ, Glimcher LH 2000 The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J Exp Med 191:9-22
28. Chen M, O'Connor KL 2005 Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells. Oncogene 24:5125-5130
29. Aoki N, Matsuda T 2002 A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol Endocrinol 16:58-69
30. Gutzman JH, Rugowski DE, Nikolai SE, Schuler LA 2007 Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin- initiated signals in tumorigenesis dependent on cell context. Oncogene 26:6341-6348
31. Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia- Barchino MJ, Rui H, Schuler LA 2011 Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. Breast Cancer Res 13:R11
32. Zheng J, Koblinski JE, Dutson LV, Feeney YB, Clevenger CV 2008 Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Cancer Res 68: 7769-7778
33. Fang F, Antico G, Zheng J, Clevenger CV 2008 Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter. BMC Biotechnol 8:11
34. Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, Miyajima A, Kitamura T 1998 Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 18:3871-3879
35. Nolz JC, Fernandez-Zapico ME, Billadeau DD 2007 TCR/CD28- stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation. J Immunol 179:1104-1112
36. Fang F, Flegler AJ, Du P, Lin S, Clevenger CV 2009 Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am J Pathol 174:297-308
37. McHale K, Tomaszewski JE, Puthiyaveettil R, Livolsi VA, Clevenger CV 2008 Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol 21:565-571